FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:GFPT1-GATA6

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: GFPT1-GATA6
FusionPDB ID: 32970
FusionGDB2.0 ID: 32970
HgeneTgene
Gene symbol

GFPT1

GATA6

Gene ID

2673

2627

Gene nameglutamine--fructose-6-phosphate transaminase 1GATA binding protein 6
SynonymsCMS12|CMSTA1|GFA|GFAT|GFAT 1|GFAT1|GFAT1m|GFPT|GFPT1L|MSLG-
Cytomap

2p13.3

18q11.2

Type of geneprotein-codingprotein-coding
Descriptionglutamine--fructose-6-phosphate aminotransferase [isomerizing] 1D-fructose-6-phosphate amidotransferase 1glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1glutamine:fructose-6-phosphate amidotransferase 1hexosephosphate aminotransferastranscription factor GATA-6GATA-binding factor 6
Modification date2020031320200313
UniProtAcc

Q06210

Main function of 5'-partner protein: FUNCTION: Controls the flux of glucose into the hexosamine pathway. Most likely involved in regulating the availability of precursors for N- and O-linked glycosylation of proteins. Regulates the circadian expression of clock genes ARNTL/BMAL1 and CRY1.

Q92908

Main function of 5'-partner protein: FUNCTION: Transcriptional activator (PubMed:19666519, PubMed:27756709, PubMed:22750565, PubMed:22824924). Regulates SEMA3C and PLXNA2 (PubMed:19666519). Involved in gene regulation specifically in the gastric epithelium (PubMed:9315713). May regulate genes that protect epithelial cells from bacterial infection (PubMed:16968778). Involved in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression (By similarity). Binds to BMP response element (BMPRE) DNA sequences within cardiac activating regions (By similarity). In human skin, controls several physiological processes contributing to homeostasis of the upper pilosebaceous unit. Triggers ductal and sebaceous differentiation as well as limits cell proliferation and lipid production to prevent hyperseborrhoea. Mediates the effects of retinoic acid on sebocyte proliferation, differentiation and lipid production. Also contributes to immune regulation of sebocytes and antimicrobial responses by modulating the expression of anti-inflammatory genes such as IL10 and pro-inflammatory genes such as IL6, TLR2, TLR4, and IFNG. Activates TGFB1 signaling which controls the interfollicular epidermis fate (PubMed:33082341). {ECO:0000250|UniProtKB:Q61169, ECO:0000269|PubMed:16968778, ECO:0000269|PubMed:19666519, ECO:0000269|PubMed:22750565, ECO:0000269|PubMed:22824924, ECO:0000269|PubMed:27756709, ECO:0000269|PubMed:33082341, ECO:0000269|PubMed:9315713}.
Ensembl transtripts involved in fusion geneENST idsENST00000357308, ENST00000361060, 
ENST00000494201, 
ENST00000269216, 
ENST00000581694, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score8 X 10 X 6=4807 X 5 X 5=175
# samples 117
** MAII scorelog2(11/480*10)=-2.12553088208386
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(7/175*10)=-1.32192809488736
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: GFPT1 [Title/Abstract] AND GATA6 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: GFPT1 [Title/Abstract] AND GATA6 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)GFPT1(69585460)-GATA6(19780618), # samples:1
Anticipated loss of major functional domain due to fusion event.GFPT1-GATA6 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
GFPT1-GATA6 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
GFPT1-GATA6 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
GFPT1-GATA6 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
GFPT1-GATA6 seems lost the major protein functional domain in Tgene partner, which is a transcription factor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneGATA6

GO:0000122

negative regulation of transcription by RNA polymerase II

18177748

TgeneGATA6

GO:0006366

transcription by RNA polymerase II

19666519

TgeneGATA6

GO:0045766

positive regulation of angiogenesis

21127043

TgeneGATA6

GO:0045892

negative regulation of transcription, DNA-templated

18177748

TgeneGATA6

GO:0060575

intestinal epithelial cell differentiation

9566909

TgeneGATA6

GO:0070848

response to growth factor

21127043

TgeneGATA6

GO:0071158

positive regulation of cell cycle arrest

9593712

TgeneGATA6

GO:0071456

cellular response to hypoxia

21127043

TgeneGATA6

GO:0110024

positive regulation of cardiac muscle myoblast proliferation

25068583



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:69585460/chr18:19780618)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across GFPT1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across GATA6 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000357308GFPT1chr269585460-ENST00000581694GATA6chr1819780618+947722179889236
ENST00000361060GFPT1chr269585460-ENST00000581694GATA6chr1819780618+945720177887236

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000357308ENST00000581694GFPT1chr269585460-GATA6chr1819780618+0.0028434870.9971565
ENST00000361060ENST00000581694GFPT1chr269585460-GATA6chr1819780618+0.0028101890.9971898

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for GFPT1-GATA6

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
GFPT1chr269585460GATA6chr1819780618720181SFTTLVERVIQQLAGAPVMTGAGEST
GFPT1chr269585460GATA6chr1819780618722181SFTTLVERVIQQLAGAPVMTGAGEST

Top

Potential FusionNeoAntigen Information of GFPT1-GATA6 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
GFPT1-GATA6_69585460_19780618.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:01QQLAGAPVM0.99520.94551019
GFPT1-GATA6chr269585460chr1819780618722HLA-B45:01VERVIQQLA0.99010.7632514
GFPT1-GATA6chr269585460chr1819780618722HLA-B39:01QQLAGAPVM0.98730.97921019
GFPT1-GATA6chr269585460chr1819780618722HLA-B48:01QQLAGAPVM0.98710.82451019
GFPT1-GATA6chr269585460chr1819780618722HLA-B39:13QQLAGAPVM0.95910.98521019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:25QQLAGAPVM0.94480.96811019
GFPT1-GATA6chr269585460chr1819780618722HLA-B50:02VERVIQQLA0.93860.5467514
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:03QQLAGAPVM0.93370.92411019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:02QQLAGAPVM0.93310.96971019
GFPT1-GATA6chr269585460chr1819780618722HLA-A30:08RVIQQLAGA0.93280.9197716
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:18QQLAGAPVM0.9240.87921019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:10QQLAGAPVM0.88430.77241019
GFPT1-GATA6chr269585460chr1819780618722HLA-B47:01QQLAGAPVM0.76380.56981019
GFPT1-GATA6chr269585460chr1819780618722HLA-B13:02QQLAGAPVM0.75780.98611019
GFPT1-GATA6chr269585460chr1819780618722HLA-B13:01QQLAGAPVM0.74170.99661019
GFPT1-GATA6chr269585460chr1819780618722HLA-A02:21RVIQQLAGA0.69080.6987716
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:37QQLAGAPVM0.63750.75571019
GFPT1-GATA6chr269585460chr1819780618722HLA-B41:01VERVIQQLA0.55220.8179514
GFPT1-GATA6chr269585460chr1819780618722HLA-B50:01VERVIQQLA0.30930.7326514
GFPT1-GATA6chr269585460chr1819780618722HLA-B73:01ERVIQQLA0.99840.7883614
GFPT1-GATA6chr269585460chr1819780618722HLA-B40:06VERVIQQLA0.99290.79514
GFPT1-GATA6chr269585460chr1819780618722HLA-B39:09QQLAGAPVM0.98870.9571019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:04QQLAGAPVM0.96410.96791019
GFPT1-GATA6chr269585460chr1819780618722HLA-B39:08QQLAGAPVM0.94030.96991019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:21QQLAGAPVM0.93350.95631019
GFPT1-GATA6chr269585460chr1819780618722HLA-B48:03QQLAGAPVM0.92750.85831019
GFPT1-GATA6chr269585460chr1819780618722HLA-B39:05QQLAGAPVM0.92570.97631019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:05QQLAGAPVM0.86420.93831019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:31QQLAGAPVM0.86070.94161019
GFPT1-GATA6chr269585460chr1819780618722HLA-A02:05RVIQQLAGA0.78140.504716
GFPT1-GATA6chr269585460chr1819780618722HLA-B73:01ERVIQQLAGA0.97990.9416616
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:125QQLAGAPVM0.99520.94551019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:34QQLAGAPVM0.99520.94551019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:33QQLAGAPVM0.99520.94551019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:27QQLAGAPVM0.99510.96051019
GFPT1-GATA6chr269585460chr1819780618722HLA-B39:02QQLAGAPVM0.98930.98411019
GFPT1-GATA6chr269585460chr1819780618722HLA-B39:31QQLAGAPVM0.98840.97941019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:50QQLAGAPVM0.9870.95511019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:12QQLAGAPVM0.94850.89861019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:39QQLAGAPVM0.94330.94131019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:73QQLAGAPVM0.93380.98721019
GFPT1-GATA6chr269585460chr1819780618722HLA-B40:12QQLAGAPVM0.92750.85831019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:53QQLAGAPVM0.92630.93831019
GFPT1-GATA6chr269585460chr1819780618722HLA-B39:11QQLAGAPVM0.8980.94941019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:54QQLAGAPVM0.88080.93141019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:68QQLAGAPVM0.87940.80261019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:20QQLAGAPVM0.86140.96081019
GFPT1-GATA6chr269585460chr1819780618722HLA-B35:28QQLAGAPVM0.85590.96491019
GFPT1-GATA6chr269585460chr1819780618722HLA-B40:49QQLAGAPVM0.84490.84261019
GFPT1-GATA6chr269585460chr1819780618722HLA-B40:21QQLAGAPVM0.84270.86881019
GFPT1-GATA6chr269585460chr1819780618722HLA-B48:02QQLAGAPVM0.83590.9571019
GFPT1-GATA6chr269585460chr1819780618722HLA-B35:20QQLAGAPVM0.83590.96581019
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:30QQLAGAPVM0.82270.98731019
GFPT1-GATA6chr269585460chr1819780618722HLA-B35:13QQLAGAPVM0.77810.92641019
GFPT1-GATA6chr269585460chr1819780618722HLA-A02:03RVIQQLAGA0.74710.7156716
GFPT1-GATA6chr269585460chr1819780618722HLA-A02:14RVIQQLAGA0.69450.676716
GFPT1-GATA6chr269585460chr1819780618722HLA-A02:06RVIQQLAGA0.69080.6987716
GFPT1-GATA6chr269585460chr1819780618722HLA-B15:09QQLAGAPVM0.68330.95021019
GFPT1-GATA6chr269585460chr1819780618722HLA-B50:05VERVIQQLA0.30930.7326514
GFPT1-GATA6chr269585460chr1819780618722HLA-B50:04VERVIQQLA0.30930.7326514

Top

Potential FusionNeoAntigen Information of GFPT1-GATA6 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
GFPT1-GATA6_69585460_19780618.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
GFPT1-GATA6chr269585460chr1819780618722DRB1-0101ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0101VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0101LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0101RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-0102ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0102VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0102LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0102RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-0103ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0103VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0105ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0105VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0105LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0105RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-0107ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0107VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0107LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0107RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-0109ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0109VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0109RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-0111ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0111VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0111LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0111RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-0113ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0113VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0115ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0115VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0117ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0117VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0117LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0117RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-0119ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0119VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0119LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0119RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-0121ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0121VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0121LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0123ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0123VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0123RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-0123LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0125ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0125VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0125LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0125RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-0127ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0127VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0127LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0127RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-0129ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0129VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0129RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-0129LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0131ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-0131VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-0131LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-0131RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-1002ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1002VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1201ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1201VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1201LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1203ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1203VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1203LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1205ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1205VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1205LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1206ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1206VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1206LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1207ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1207VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1207LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1208ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1208VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1210ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1210VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1210LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1211ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1211VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1211LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1212ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1212VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1212LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1213ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1213VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1213LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1214ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1214VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1214LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1215ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1215VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1215LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1216ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1216VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1217ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1217VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1217LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1218ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1218VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1218LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1219ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1219VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1219LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1220ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1220VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1221ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1221VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1221LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1221RVIQQLAGAPVMTGA722
GFPT1-GATA6chr269585460chr1819780618722DRB1-1222ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1222VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1223ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1223VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1223LVERVIQQLAGAPVM419
GFPT1-GATA6chr269585460chr1819780618722DRB1-1504ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1521ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1534ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1601ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1603ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1604ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1608ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1615ERVIQQLAGAPVMTG621
GFPT1-GATA6chr269585460chr1819780618722DRB1-1615VERVIQQLAGAPVMT520
GFPT1-GATA6chr269585460chr1819780618722DRB1-1615LVERVIQQLAGAPVM419

Top

Fusion breakpoint peptide structures of GFPT1-GATA6

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
2109ERVIQQLAGAPVMTGFPT1GATA6chr269585460chr1819780618722

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of GFPT1-GATA6

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN2109ERVIQQLAGAPVMT-7.15543-7.26883
HLA-B14:023BVN2109ERVIQQLAGAPVMT-4.77435-5.80965
HLA-B52:013W392109ERVIQQLAGAPVMT-6.80875-6.92215
HLA-B52:013W392109ERVIQQLAGAPVMT-4.20386-5.23916
HLA-A11:014UQ22109ERVIQQLAGAPVMT-7.5194-8.5547
HLA-A11:014UQ22109ERVIQQLAGAPVMT-6.9601-7.0735
HLA-A24:025HGA2109ERVIQQLAGAPVMT-7.52403-7.63743
HLA-A24:025HGA2109ERVIQQLAGAPVMT-5.82433-6.85963
HLA-B27:056PYJ2109ERVIQQLAGAPVMT-3.28285-4.31815
HLA-B44:053DX82109ERVIQQLAGAPVMT-5.91172-6.94702
HLA-B44:053DX82109ERVIQQLAGAPVMT-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of GFPT1-GATA6

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
GFPT1-GATA6chr269585460chr18197806181019QQLAGAPVMCAACAATTGGCGGGTGCCCCGGTGATG
GFPT1-GATA6chr269585460chr1819780618514VERVIQQLAGTGGAGAGAGTTATCCAACAATTGGCG
GFPT1-GATA6chr269585460chr1819780618614ERVIQQLAGAGAGAGTTATCCAACAATTGGCG
GFPT1-GATA6chr269585460chr1819780618616ERVIQQLAGAGAGAGAGTTATCCAACAATTGGCGGGTGCC
GFPT1-GATA6chr269585460chr1819780618716RVIQQLAGAAGAGTTATCCAACAATTGGCGGGTGCC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
GFPT1-GATA6chr269585460chr1819780618419LVERVIQQLAGAPVMTTGGTGGAGAGAGTTATCCAACAATTGGCGGGTGCCCCGGTGATG
GFPT1-GATA6chr269585460chr1819780618520VERVIQQLAGAPVMTGTGGAGAGAGTTATCCAACAATTGGCGGGTGCCCCGGTGATGACT
GFPT1-GATA6chr269585460chr1819780618621ERVIQQLAGAPVMTGGAGAGAGTTATCCAACAATTGGCGGGTGCCCCGGTGATGACTGGT
GFPT1-GATA6chr269585460chr1819780618722RVIQQLAGAPVMTGAAGAGTTATCCAACAATTGGCGGGTGCCCCGGTGATGACTGGTGCG

Top

Information of the samples that have these potential fusion neoantigens of GFPT1-GATA6

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADGFPT1-GATA6chr269585460ENST00000357308chr1819780618ENST00000581694TCGA-IN-AB1V

Top

Potential target of CAR-T therapy development for GFPT1-GATA6

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to GFPT1-GATA6

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to GFPT1-GATA6

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource